Sort
51,593 grants matching “hepatitis”
RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse
$670,501Rae Jean Elizabeth Proeschold-Bell · Duke University · R01 · FY2015 · AA
Endovascular Filtration to Change Drug Biodistribution (ELOCUTION)
$670,440Steven William Hetts · University Of California, San Francisco · R01 · FY2025 · EB
Comparing the effects of pharmacological treatment for gestational diabetes on long-term maternal and child health outcomes
$670,325Monique Marie Hedderson · Kaiser Foundation Research Institute · R01 · FY2024 · DK
Role of IRF3 in Energy and Glucose Homeostasis
$670,248Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK
Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan
$670,212Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2010 · DA
RESEARCH CORE
$670,122Chau Trinh-Shevrin · New York University School Of Medicine · P60 · FY2009 · MD
Homeostatic Responses to Amino Acid Insufficiency
$669,968Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2022 · DK
Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family
$669,949Aras Nikodemas Mattis · University Of California, San Francisco · R01 · FY2024 · DK
Corepressor regulation of nuclear receptor action
$669,900Anthony N Hollenberg · Boston University Medical Campus · R01 · FY2023 · DK
Reducing risk of Anthracycline-related heart failure after childhood cancer
$669,859Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial
$669,837Marina Serper · University Of Pennsylvania · R01 · FY2025 · DK
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$669,821Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes
$669,816Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2024 · HL
Stroke with Transfusions Changing to Hydroxyurea (SWITCH) Trial Data Coordinating
$669,802Ronald W. Helms · Rho Federal Systems Division, Inc. · U01 · FY2009 · HL
Viral Hepatitis Prevention and Surveillance
$669,798Guthrie S Birkhead · Nysdoh/Health Research, Inc. · U51 · FY2014 · PS
Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment
$669,786James S Duncan · Yale University · R01 · FY2016 · CA
Clinical
$669,770Rajesh T Gandhi · Harvard University · P30 · FY2012 · AI
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
$669,737Mark John Ranek · Johns Hopkins University · R56 · FY2023 · HL
Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors
$669,728Ju-Tao Guo · Baruch S. Blumberg Institute · R01 · FY2015 · AI
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
$669,713Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Mechanisms Regulating Neurotensin Secretion and Function
$669,684Bernard Mark Evers · University Of Kentucky · R01 · FY2023 · DK
Mechanisms Regulating Neurotensin Secretion and Function
$669,684Bernard Mark Evers · University Of Kentucky · R01 · FY2022 · DK
Mechanisms Regulating Neurotensin Secretion and Function
$669,684Bernard Mark Evers · University Of Kentucky · R01 · FY2025 · DK
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
$669,602Heidi M. Crane · University Of Washington · U01 · FY2020 · AA
Body Composition & REE Responses to Bariatric Surgeries
$669,530Dympna Gallagher · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2007 · DK